03:46 AM EST, 01/09/2026 (MT Newswires) -- Monte Rosa Therapeutics ( GLUE ) said late Thursday it priced an underwritten public offering of 11.1 million shares at $24 per share.
The company said it also issued pre-funded warrants to certain investors to purchase 1.4 million shares at $23.9999 per warrant.
Monte Rosa said it granted the underwriters a 30-day option to buy up to an additional 1.9 million shares at the offering price, less underwriting discounts and commissions.
Gross proceeds from the offering, expected to close on Monday, would be about $300 million, it added.